Navigation Links
Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions
Date:3/27/2008

Information Technology

-- By combining multimodality, diagnostic image management from syngo(R)

Dynamics with the nursing documentation, orders, and outcomes analysis

capabilities of Soarian Cardiology, the Soarian Cardiology and syngo

Dynamics solution provides powerful procedural and episodic care

reporting capabilities and a cardiovascular electronic patient record

(EPR) that supports the cardiac care process. With Soarian Cardiology

and syngo Dynamics, Siemens advances its trendsetting strategy of

delivering end-to-end IT, imaging and workflow solutions. In a

clinical environment where images are critical to the care of a

patient, physicians need all images and data accessible at one

workstation and available via a longitudinal clinical repository. This

solution helps enable the goal of a seamless, optimized workflow for

the care of the cardiovascular patient.

Cardiovascular MR

-- The combination of advanced speed and higher resolution images has

expanded the role of magnetic resonance imaging in cardiology.

syngo(R) Inline VF, new from Siemens, enables fully automatic

detection of heart contours and cardiac wall motion during image

acquisition. Now, this software can help physicians more accurately

assess cardiac function immediately after a scan.

Molecular Imaging

-- True efficiency and integration are achieved with Siemens' cardiology

solutions, including c.cam(TM), Symbia SPECT, Symbia SPECT-CT, and

Biograph PET-CT systems. Siemens' MI solutions provide cardiologists

with functional information, such as wall motion, myocardial

perfusion, and in some cases, plaque characterization, as well as

morphological information, such as the presence of coronary

calcifications. Siemens will also highlight PETN
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
2. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
3. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
4. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
5. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
6. World Debut for BSPs HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
7. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
8. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
9. New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance
10. Siemens to Launch PETNET Services in India
11. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...CET, AMSTERDAM, February 20 Amsterdam Molecular,...d of human gene therapy,today reported its full ye..., raising gross proceeds of EUR 55.7 million - Ca...30, 2007 - U.S. FDA orphan drug designation for l.../II in LPL type I deficiency - Pre-registration t...
...emonstrated by a collaboration between researchers...logy (NIST), Penn State and the University of Kent...duce large arrays of organic electronic transistor...ns including flexible displays, intelligent paper ...diagnostics. , In a paper posted this week,* the ...
...ion,(Nasdaq: KNSY ) is scheduled to present at th... at the Mission Bay Conference Center in San,Franc..., Kensey Nash,s Chief Operating Officer, will deli...ately at 2:50 p.m. (PT). The,presentation material...p://www.kenseynash.com ) beginning at 2:50 p.m. (P...
Other Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2007 2Amsterdam Molecular Therapeutics Reports Full Year Results 2007 3Amsterdam Molecular Therapeutics Reports Full Year Results 2007 4Amsterdam Molecular Therapeutics Reports Full Year Results 2007 5Amsterdam Molecular Therapeutics Reports Full Year Results 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 7Directed self-ordering of organic molecules for electronic devices 2
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 1Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 2Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 3News brief 3A Effects of aspirin and folic acid on inflammation markers for colorectal adenomas 59312 1Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2
...pression of genes may be the reason why people who...ckly develop a tolerance, biologists at The Univer...eam, led by graduate student Yan Wang, used the fr...to determine how the nervous system becomes tolera...The team,s work appears in the October 16 issue of...
...ore acid, with potentially devastating consequence...eefs and provide much of the Earths breathable oxy...up of carbon dioxide (CO 2 ) in the atmosphere, di... be lethal for animals with chalky skeletons which...ife. , Acid oceans will be among the issues explo...
...DED BROKERAGE TO UTILIZE TITANIUM,S ... Oct. 16 Titanium Group, Ltd,(OTC Bulletin Board:...s,provider announced today that it has signed a co...) (SHA: 600837). Titanium will install its,Biometr...ated office in,Hong Kong. Haitong, listed in the S...
Other Biology News:Tolerance to inhalants may be caused by changes in gene expression 2Acid oceans warning 2Titanium Group Announces Contract With Haitong Securities 2Titanium Group Announces Contract With Haitong Securities 3Titanium Group Announces Contract With Haitong Securities 4
Mouse Anti-Human ACP2 Monoclonal Antibody, Unconjugated, Clone M1-4A12 from Novus Biologicals
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
...ew IKATUBE ULTRA TURRAX Tube Disperser System from... system. It offers a cleaner, safer, and more effi...processes sample volumes from 2 to 15 ml inside se...chers can choose one of 4 different tube types. Ea...
...ewest member of Wyatt Technology's family of light...our high temperature chromatograph and enables you...rmoplastic polymers. The HTmD is easily installed ... 2000 device and enables you to get three angles o...
Biology Products: